Platelet-to-lymphocyte ratio, a novel biomarker to predict the severity of COVID-19 patients: A systematic review and meta-analysis
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Platelet-to-lymphocyte ratio (PLR), a novel inflammatory marker, has been suggested to predict the severity of COVID-19 patients. This systematic review aims to evaluate the association between PLR levels on admission and the severity of COVID-19 patients. A systematic literature search was done on 23 July 2020 to identify peer-reviewed studies, preprints, and grey literatures. Research articles comparing the PLR value on admission in adult patients with COVID-19 with varying degrees of severity were included in the analysis. The following keywords were used for the search: “COVID-19”, “PLR”, “severity”, and “mortality”. A total of seven studies were included in the meta-analysis, six of which were conducted in China. From a total of 998 participants included, 316 (31.7%) had severe diseases; and those in the severe group were generally older and had underlying diseases compared to the non-severe group. In comparison to non-severe patients, the meta-analysis showed that severe COVID-19 patients had higher PLR levels on admission (SMD 0.68; 95%CI 0.43-0.93; I 2 =58%). High PLR levels on admission were associated with severe COVID-19 cases. Therefore, the on-admission PLR level is a novel, cost-effective, and readily available biomarker with a promising prognostic role for determining the severity of COVID-19 patients.
Article activity feed
-
SciScore for 10.1101/2020.08.21.20166355: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources A systematic literature search was finalized on 23 July 2020 to identify peer-reviewed papers published in four databases (Ovid MEDLINE, EMBASE, SCOPUS, and the Cochrane Library). EMBASEsuggested: (EMBASE, RRID:SCR_001650)Cochrane Librarysuggested: (Cochrane Library, RRID:SCR_013000)Statistical Analysis: For the quantitative analysis, we exported quantitative data from all eligible studies to Review Manager software 5.3 (Cochrane Collaboration) and performed a meta-analysis. Revi…SciScore for 10.1101/2020.08.21.20166355: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources A systematic literature search was finalized on 23 July 2020 to identify peer-reviewed papers published in four databases (Ovid MEDLINE, EMBASE, SCOPUS, and the Cochrane Library). EMBASEsuggested: (EMBASE, RRID:SCR_001650)Cochrane Librarysuggested: (Cochrane Library, RRID:SCR_013000)Statistical Analysis: For the quantitative analysis, we exported quantitative data from all eligible studies to Review Manager software 5.3 (Cochrane Collaboration) and performed a meta-analysis. Review Managersuggested: NoneCochrane Collaborationsuggested: NoneThe statistical heterogeneity between the studies was assessed using Cochrane chi-square and I2. Cochrane chi-squaresuggested: NoneResults from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:This meta-analysis is not without limitations. We acknowledge that only including articles written and published in English would disregard those written in other languages, and thus present with geographical bias. Moreover, most of the included studies were from China, whereas the majority of confirmed cases and deaths were located in the USA and Europe. The variability in PLR values between different populations could limit the relevance of this finding. Based on the funnel plot, we also identified a potential risk of publication bias. In addition, the limited data presented by the included studies did not allow further stratification of the severe group into severe and critically ill patients. Therefore, further research still needs to be conducted to determine an optimal cut-off value for PLR value for the prediction of severity in COVID-19.
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
-